Clinical feasibility of ultra-rapid, non-pharmacologic anesthesia for intravitreal injection in patients receiving anti-VEGF treatment

被引:0
|
作者
Besirli, Cagri G. [1 ]
Smith, Stephen [2 ]
Pipe, Kevin [3 ]
Kim, Gunho [3 ]
Zacks, David N. [1 ]
Gardner, Thomas W. [1 ]
Shah, Anjali [1 ]
机构
[1] Univ Michigan, Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA
[2] Stanford Univ, Ophthalmol, Palo Alto, CA 94304 USA
[3] Univ Michigan, Mech Engn, Ann Arbor, MI 48109 USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1618
引用
收藏
页数:3
相关论文
共 50 条
  • [11] The experience of patients and practitioners of intravitreal anti-VEGF injection procedures and the associated factors
    Yiallouridou, Christina
    Acton, Jennifer H.
    Banerjee, Sanjiv
    Waterman, Heather
    Wood, Ashley
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [12] Treatment contentment and preference of patients undergoing intravitreal anti-VEGF therapy
    Kellner, Ulrich
    Bedar, Mohammad Seleman
    Weinitz, Silke
    Farmand, Ghazaleh
    Sueruel, Ebru Nida
    Weide, Sara Maria
    Schick, Tina
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (12) : 3649 - 3654
  • [13] Treatment contentment and preference of patients undergoing intravitreal anti-VEGF therapy
    Ulrich Kellner
    Mohammad Seleman Bedar
    Silke Weinitz
    Ghazaleh Farmand
    Ebru Nida Sürül
    Sara Maria Weide
    Tina Schick
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 3649 - 3654
  • [14] Clinical Outcomes of Endophthalmitis in Early and Late Presentation after Intravitreal Anti-VEGF Injection
    Uner, Ogul Ersin
    Lee, Diana
    Seebruck, Christopher
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [15] Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection
    Merani, Rohan
    Johnson, Mark W.
    McCannel, Colin A.
    Flynn, Harry W., Jr.
    Scott, Ingrid U.
    Hunyor, Alex P.
    JOURNAL OF VITREORETINAL DISEASES, 2022, 6 (06) : 443 - 451
  • [16] Glaucoma progression in patients receiving intravitreal anti-VEGF treatment for neovascular age-related macular degeneration
    Pirinen, Inka
    Leinonen, Sanna
    Helminen, Mika
    Hujanen, Pekko
    Vaajanen, Anu
    Tuulonen, Anja
    Uusitalo-Jaervinen, Hannele
    ACTA OPHTHALMOLOGICA, 2023, 101 (03) : 261 - 265
  • [17] Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients
    Xu, Yue
    Xie, Chi
    Fang, Yan
    Yu, Yan
    Qiu, Cui
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2022, 15 (10) : 1619 - 1626
  • [18] Is there an individual re-injection frequency in patients treated with intravitreal anti-VEGF for AMD?
    Lehmann, Fabian
    Helbig, Horst
    Gamulescu, Maria Andreea
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [19] Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients
    Yue Xu
    Chi Xie
    Yan Fang
    Yan Yu
    Cui Qiu
    International Journal of Ophthalmology, 2022, 15 (10) : 1619 - 1626
  • [20] Endophthalmitis rates among patients receiving intravitreal anti-VEGF injections: a USA claims analysis
    Kiss, Szilard
    Dugel, Pravin U.
    Khanani, Arshad M.
    Broder, Michael S.
    Chang, Eunice
    Sun, Gordon H.
    Turpcu, Adam
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 1625 - 1635